IFM Investors Pty Ltd increased its position in Cerner Co. (NASDAQ:CERN) by 60.2% in the 3rd quarter, Holdings Channel.com reports. The firm owned 36,248 shares of the company’s stock after buying an additional 13,618 shares during the quarter. IFM Investors Pty Ltd’s holdings in Cerner were worth $2,471,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of the stock. Acropolis Investment Management LLC raised its holdings in shares of Cerner by 2.0% during the second quarter. Acropolis Investment Management LLC now owns 7,494 shares of the company’s stock worth $549,000 after purchasing an additional 148 shares during the period. Advisor Partners LLC grew its position in shares of Cerner by 2.2% during the second quarter. Advisor Partners LLC now owns 7,061 shares of the company’s stock worth $518,000 after acquiring an additional 154 shares during the last quarter. Wetherby Asset Management Inc. grew its position in shares of Cerner by 5.5% during the third quarter. Wetherby Asset Management Inc. now owns 3,330 shares of the company’s stock worth $227,000 after acquiring an additional 174 shares during the last quarter. Destination Wealth Management grew its position in shares of Cerner by 3.7% during the second quarter. Destination Wealth Management now owns 5,208 shares of the company’s stock worth $382,000 after acquiring an additional 187 shares during the last quarter. Finally, Clarius Group LLC grew its position in shares of Cerner by 6.3% during the third quarter. Clarius Group LLC now owns 3,245 shares of the company’s stock worth $221,000 after acquiring an additional 192 shares during the last quarter. 83.82% of the stock is currently owned by hedge funds and other institutional investors.

Shares of NASDAQ:CERN traded down $0.38 during trading hours on Friday, hitting $66.45. 14,425 shares of the company’s stock traded hands, compared to its average volume of 2,007,820. Cerner Co. has a 52 week low of $48.78 and a 52 week high of $76.47. The company has a debt-to-equity ratio of 0.24, a quick ratio of 2.19 and a current ratio of 2.21. The company’s fifty day simple moving average is $67.44 and its two-hundred day simple moving average is $69.66. The company has a market cap of $21.11 billion, a price-to-earnings ratio of 30.05, a price-to-earnings-growth ratio of 2.11 and a beta of 0.92.

Cerner (NASDAQ:CERN) last posted its quarterly earnings data on Thursday, October 24th. The company reported $0.66 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.66. Cerner had a net margin of 9.02% and a return on equity of 15.61%. The company had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.43 billion. During the same quarter last year, the firm posted $0.63 EPS. The business’s revenue for the quarter was up 6.7% on a year-over-year basis. On average, analysts anticipate that Cerner Co. will post 2.41 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, October 9th. Stockholders of record on Wednesday, September 25th were given a dividend of $0.18 per share. The ex-dividend date of this dividend was Tuesday, September 24th. This represents a $0.72 annualized dividend and a dividend yield of 1.08%. Cerner’s dividend payout ratio (DPR) is 32.58%.

In other Cerner news, Director Julie L. Gerberding sold 7,928 shares of the company’s stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $71.82, for a total transaction of $569,388.96. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Donald Trigg sold 29,423 shares of the company’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $67.72, for a total transaction of $1,992,525.56. Following the sale, the vice president now directly owns 256,354 shares of the company’s stock, valued at $17,360,292.88. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 344,268 shares of company stock valued at $23,243,010. Insiders own 0.75% of the company’s stock.

A number of brokerages recently issued reports on CERN. Cowen set a $66.00 target price on shares of Cerner and gave the company a “hold” rating in a research report on Friday, October 25th. Citigroup increased their target price on shares of Cerner from $77.00 to $84.00 and gave the company a “buy” rating in a research report on Thursday, July 25th. Bank of America set a $83.00 target price on shares of Cerner and gave the company a “buy” rating in a research report on Friday, October 25th. Wells Fargo & Co increased their target price on shares of Cerner from $72.00 to $80.00 and gave the company an “outperform” rating in a research report on Thursday, July 25th. Finally, Deutsche Bank began coverage on shares of Cerner in a research report on Thursday, September 26th. They issued a “buy” rating and a $82.00 target price for the company. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and eleven have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $76.73.

Cerner Profile

Cerner Corporation provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.

See Also: What is a dividend reinvestment plan?

Want to see what other hedge funds are holding CERN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cerner Co. (NASDAQ:CERN).

Institutional Ownership by Quarter for Cerner (NASDAQ:CERN)

Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.